Alopecia Treatment Market Growth, Market Insights and Forecast to 2025

Posted by rekha on December 4th, 2019

The Global Alopecia Treatment Market increasing at a substantial growth rate over the forecast years 2019-2025 to reach US$ 8,478.2 Mn by 2025 owing to surge in prevalence of Alopecia due to surge in aging population coupled with change in lifestyle

The global alopecia treatment market was valued at US$ XX Mn in 2018 and growing at a norable CAGR over the forecast years due to increase in the prevalence of alopecia around the world. Moreover, increase in the R&D expenditure for the development of newer therapeutics, surge in aging population, increase in prevalence of hormonal imbalance, PCOD/PCOS, surge in prevalence of chronic diseases such as hypertension, cancer, depression, and rise in healthcare expenditure are anticipated to propel the global Alopecia treatment market over the forecast years. However, high cost of treatment, adverse effects with long term administration of medication, and stringent regulations for the product approval are hamper the growth of alopecia treatment market over the forecast timeframe

Global alopecia treatment market segmented on the basis of drug type, disease type, route of administration, sales channel, gender, and distribution channel

Request For Sample Report @

Alopecia Areata Dominate the Global Alopecia Treatment Market

Based on the disease type, global alopecia treatment market segmented into alopecia areata, alopecia totalis, alopecia universalis, androgenetic alopecia, and others. Among all the diseases, alopecia areata dominated the global Alopecia treatment market in 2018 and the same trend is expected over the forecast years owing to increase in the prevalence of alopecia areata across the globe. For instance, according to a research study, the prevalence of alopecia is gradually increasing and it is approximately 1 in 1000 people, with a lifetime risk of approximately 2 percent. Moreover, increase in the increase in the incidence of autoimmune disorders such as type-1 diabetes and rheumatoid arthritis also surge the market over the forecast years. In addition, androgenetic alopecia expected to grow at significant CAGR over the forecast years owing to promising pipeline drugs for the treatment.

North America Leads the Global Alopecia Treatment market

PBI’s global Alopecia treatment market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to surge in the prevalence of Alopecia disease in USA and Canada. For instance, according to National Alopecia Areata Foundation, approximately it affects as many as 6.8 million people in the U.S. with a lifetime risk of 2.1%. Moreover, favorable reimbursement policies, increase in the R&D activities for the development of newer therapeutics, and surge in healthcare expenditure are bolster the market over the forecast years. Asia Pacific Alopecia treatment market projected to exhibit significant growth due to rapid growth in aging population and surge in incidence of Alopecia in the region.

Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

Global Alopecia treatment market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

  • For instance. In January 2018, HCell, Inc. received Orphan Drug Designation from USFDA for HC017AA for the treatment of pediatric patients with Alopecia Areata

Key player’s profiles in the report are Histogen Inc., HCell, Inc., Cipla Limited, Precision TherapeuticsInc., Aclaris Therapeutics, Inc., Merck & Co., Inc., Perrigo Company PLC, Concert Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, and Sun Pharmaceutical Industries Ltd

Precision Business Insights (PBI) in its report titled “Global Alopecia Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Detailed Segmentation

By Drug Class

o    Topical Agents

o    5 AR Inhibitors

o    Corticosteroids

o    Others

By Disease Type Class

o    Alopecia Areata

o    Alopecia Totalis

o    Alopecia Universalis

o    Androgenetic Alopecia

o    Others

By Route of Administration

o    Oral

o    Topical

o    Injectable

By Sales Channel

o    OTC Drugs

o    Prescription Drugs

By Gender

o    Male

o    Female

By Distribution Channel

o    Hospital Pharmacies

o    Retail Pharmacies

o    Online Pharmacies


o     North America

  • U.S
  • Canada

o     Europe

  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

o     Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

o     Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

o     Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

For More Information:

Like it? Share it!


About the Author

Joined: July 26th, 2019
Articles Posted: 219

More by this author